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We recently reported that the epidermis of patients
with atopic dermatitis contains an abnormally
expressed sphingomyelin deacylase that yields a large
amount of sphingosylphosphorylcholine (SPC) rather
than ceramide. In this study, we characterize inflam-
matory roles of newly discovered chemicals in the
epidermis by elucidating biologic effects of SPC on
intercellular adhesion molecules-1 (ICAM-I) expres-
sion by human keratinocytes in culture in comparison
with other sphingolipids. Using fluorescence-activated
cell sorter analysis, we found that SPC treatment at
concentrations of 10–20 mM significantly enhanced the
expression of ICAM-I by cultured human keratinocytes
in a dose-dependent manner after incubation for 15–
24 h, and, using northern blot analysis, that this
was accompanied by increased expression of ICAM-1
mRNA within 4 h of incubation. Transforming nec-
rosis factor-a (TNF-a) levels in the medium of ker-
atinocytes treated at a 10 mM concentration of SPC
Recently, we demonstrated that in the epidermis ofpatients with atopic dermatitis (AD), there is anabnormal expression of a hitherto undiscoveredepidermal enzyme, sphingomyelin (SM) deacylase(Murata et al, 1996). This enzyme hydrolyzes SM
to yield sphingosylphosphorylcholine (SPC), rather than ceramides
generated by the action of sphingomyelinase (SMase), leading to
ceramide deficiency as an etiologic factor in atopic dry skin.
Sphingolipids and their metabolites have been implicated in diverse
biologic functions in various cellular processes (Hannun and Bell,
1987; Murayama and Ui, 1987; Merril and Sttevens, 1989). It has
been suggested that this complex class of lipids may play an
important role in the regulation of epidermal growth and differenti-
ation because the epidermis is extremely rich in sphingolipids and
metabolic enzymes such as SMase and ceramidase (Yada et al, 1995).
Recently, Desai and Spiegel (1991) reported that SPC is a powerful
mitogen that stimulates DNA synthesis and cellular proliferation of
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were significantly increased by 200%. Furthermore,
the SPC-induced ICAM-1 expression was partially
abolished by the concomitant addition of anti-TNF-
a, suggesting a partial autocrine involvement of TNF-
a in ICAM-1 expression. Assay of mitogen-activated
protein kinase revealed that 10 mM SPC induced a
rapid activation of mitogen-activated protein kinase
in human keratinocytes, including an increase in its
phosphorylation within 5 min, which then declined to
the baseline control level after 30 min. In contrast,
sphingomyelin or sphingosine had no significant
potential to activate mitogen-activated protein kinase
at the same concentration. These findings suggest that
SPC plays an important role in the inflammatory
process of epidermis in skin diseases, such as atopic
dermatitis, with high expression of sphingomyelin
deacylase. Key words: atopic dermatitis/sphingomyelin
deacylase/transforming necrosis factor-a. J Invest Dermatol
112:91–96, 1999
Swiss 3T3 fibroblasts and other cell types to a greater extent than
other known growth factors or structurally related molecules such
as sphingosine (SS) and SS-1-phosphate. In a parallel study (Desai
et al, 1993), SPC was shown to release calcium from inositol
trisphosphate-sensitive or -insensitive intracellular pools in permea-
bilized smooth muscle cells. Because an increase in [Ca12]i appears
to be an early and general response to stimulation of proliferation
and differentiation in epidermal cells such as keratinocytes (Hen-
nings et al, 1980), it would be of considerable interest to determine
how the biologic function of keratinocytes is affected by SPC
relevant to the excess formation of SPC in the epidermis of AD
patients and their high susceptibility to inflammation. In this study,
we attempted to characterize the inflammatory role of SPC in
human epidermis by elucidating biologic effects of SPC on intercel-
lular adhesion molecule-1 (ICAM-1) expression by human ker-
atinocytes in culture in comparison with other sphingolipids. We
report here that SPC specifically stimulates ICAM-1 expression by
keratinocytes in vitro, suggesting that the ability of SPC to act as
an inflammatory mediator may affect the predisposition of skin to
inflammatory reactions.
MATERIALS AND METHODS
Materials Normal human keratinocytes were obtained from Kyokuto
Pharmaceutical Industrial (Tokyo, Japan). Serum-free keratinocyte growth
medium (SFM) containing low calcium (0.09 mM Ca21 modified MCDB
153), bovine pituitary extract (BPE), and epidermal growth factor (EGF)
92 IMOKAWA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
were obtained from Gibco (Grand Island, NY). SPC was purchased from
BIOMOL Research Laboratories (Plymouth Meeting, PA). Human tumor
necrosis factor-α (TNF-α) and human interferon-γ (IFN-γ) were purchased
from Sigma (St. Louis, MO). Mouse monoclonal antibodies to TNF-α,
IFN-γ, and interleukin-6 (IL-6) were purchased from Serotec (Oxford,
U.K.). IL-6 was obtained from R&D System (Oxon, U.K.). Other
chemicals were of reagent grade.
Cell culture Human keratinocytes were seeded at a density of 5–8 3 104
cells per ml in SFM supplemented with 5 ng EGF per ml and 0.2% BPE
at 37°C under a 5% CO2 atmosphere. In experiments to measure effects
of SPC, human keratinocytes were cultured in SFM without EGF and BPE.
Measurement of cytokines After human keratinocytes had been cul-
tured for 24 h in SFM without EGF and BPE and treated with SPC at
concentrations of 1–10 µM for another 24–48 h, the keratinocyte-
conditioned medium was collected, and 100 µl was used to quantitate
cytokines including IL-6 (R&D System), TNF-α (Amersham, Buckingh-
amshire, U.K.), and granulocyte-macrophage colony stimulating factor
(Endogen, MA) by each enzyme-linked immunosorbent assay kit.
Assay for expression of ICAM-1 and vascular cell adhesion molec-
ule-1 Keratinocytes were seeded in 8 well tissue culture chamber slides
(Lab-Tek, Nunc, Naperville, IL) at a density of 5–8 3 104 cells per ml.
After 24 h treatment with SS derivatives in SFM without EGF and BPE,
the cells were fixed with 3.7% formaldehyde and incubated at 4°C for
24 h with fluorescein isothiocyanate-conjugated anti-ICAM-1 or vascular
cell adhesion molecule-1 antibodies (Serotec, Oxford, U.K.), followed by
three washes with phosphate-buffered saline. The intensity and localization
of fluoresence in cultured keratinocytes was observed using confocal laser
scanning microscopy (TCS4D; Leica Lasertechnik, Heidelberg, Germany).
During this experiment cytotoxic effect of SPC was checked by cell
morphology under phase contrast microscopic observation. For flow
cytometric analysis, single-cell suspensions were prepared by harvesting
cultured keratinocytes with 0.25% pronase in phosphate-buffered saline.
After washing with phosphate-buffered saline, 105 cells were incubated
with 10 µl of anti-human ICAM-1 monoclonal antibody (mouse IgG,
Serotec), followed by fluorescein isothiocyanate-conjugated anti-mouse
IgG (rabbit IgG, Medical & Biological Laboratories, Aichi, Japan), and
stained cells were analyzed in a FACScan (Becton Dickinson). During this
experiment dead cells were identified by propidium iodide staining.
Northern blots Messenger RNA were isolated from normal human
keratinocytes using a QuickPrep Micro mRNA Purification Kit (Pharmacia
Biotech, Uppsala, Sweden). The mRNA samples (10 µg per lane) were
subjected to gel electrophoresis in denaturing formaldehyde-1% agarose
gels and transfered overnight in 20 3 sodium citrate/chloride buffer (3 M
sodium chloride, 0.3 M sodium citrate, pH 7.0) to a Zeta Probe Blotting
membrane (Bio-Rad Laboratories, Hercules, CA). The membrane was UV
irradiated with an ultraviolet crosslinker (Amersham) to fix the RNA.
Blots were prehybridized for 2 h at 50°C in prehybridization solution
[6 3 sodium citrate/chloride buffer, 10 3 Denhardt solution, 1% sodium
dodecyl sulfate (SDS), 50% Formamide, 100 µg sonicated salmon sperm
DNA per ml], and hybridized overnight at 50°C with random-primed
32P-labeled probes. The 580 bp cDNA fragment (position 1066–1645) for
ICAM-1 (Stauton et al, 1988) or the 516 bp cDNA fragment (position 7–
522) for G3PDH (Allen et al, 1987) were labeled with [α-32P]dCTP using
the Mutiprime DNA labeling system (Amersham). After hybridization, the
blots were washed twice for 15 min each at 65°C in 2 3 sodium citrate/
chloride buffer with 0.1% SDS, followed by two washes for 30 min each
at 65°C in 0.2 3 sodium citrate/chloride buffer with 0.1% SDS. The
washed blots were exposed to a Fuji Imaging Plate (Fuji Photo Film,
Tokyo, Japan) for 1–2 h.
Mitogen-activated protein (MAP) kinase assay MAP kinase activity
was measured using a p42/p44 MAP kinase enzyme assay system (Amer-
sham) as the rate of phosphorylation of a synthetic peptide substrate that
is highly selective for p42/p44 MAP kinase. Briefly, human keratinocytes
were grown to confluence and the medium was exchanged for fresh SFM
without EGF and BPE. After 2–3 h culture, cells were treated with 10 µM
SPC. After 0–60 min of treatment with SPC, cells were rinsed twice with
ice-cold phosphate-buffered saline and lyzed at 4°C in 10 mM Tris,
150 mM NaCl, 2 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-
tetraacetic acid, 2 mM dithiothreitol, 1 mM orthovanadate, 1 mM
phenylmethylsulfonyl fluoride, 10 µg leupeptin(CB) per ml, and 10 µg
aprotinin per ml, pH 7.4. Cellular debris was precipitated at 25,000 3 g
for 20 min and the supernatants were obtained as cytosolic extracts. The
cytosolic extracts (15 µl) were assayed for MAP kinase activity by mixing
at 30°C with the substrate buffer (10 µl, containing HEPES, sodium
orthovanadate, 0.05% sodium azide, and the synthetic peptide, pH 7.4),
the assay buffer (containing HEPES, ATP, and magnesium chloride, pH 7.4),
and 1 µCi [γ-32P]ATP. Reactions were terminated after 0, 2, 4, 6, and
10 min by adding 10 µl stop reagent, which contains orthophosphoric
acid. The terminated reaction mixtures were spotted onto the centers of
paper disks that were then washed three times with 250 µl 75 mM
orthophosphoric acid, and twice with water. The filters were then air-
dried and counted in a scintillation counter; MAP kinase activities are
expressed as cpm per disk.
Western blotting analysis Keratinocytes were incubated with 10 µM
SPC or 100 ng EGF per ml in 60 mm diameter culture dishes. Cells were
scraped in 200 ml of ice cold extraction buffer containing 20 mM Tris-
acetate (pH 7.5), 0.27 M sucrose, 1 mM ethylenediamine tetraacetic acid,
1 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-tetraacetic acid,
1 mM sodium fluoride, 5 mM sodium pyrophosphate, 1% Triton X-100,
0.1% 2-mercaptoethanol, 1 mM benzamidine, 0.2 mM phenylmethylsul-
fonyl fluoride, and 5 µg leupeptin per ml. The mixtures were sonicated
briefly and centrifuged at 14,000 3 g for 30 min at 4°C. Protein
concentration in the supernatants were quantitated by the Bradford method
(Bio-Rad). Lysates (50 µg per lane) were separated by 10% SDS-polyacryl-
amide gel electrophoresis and transferred to immobilon-p PVDF transfer
membranes (Millipore, Eschborn, Germany). Membranes were blocked
with 3% bovine serum albumin in wash buffer (20 mM Tris-HCl, pH 7.2,
0.14 M NaCl, 0.1% Tween-20) for 3 h at room temperature, and then
probed with p44/42 MAP kinase antibody (New England Biolabs, Beverly,
MA) or phospho-specific p44/42 MAP kinase antibody (New England
Biolabs) overnight at 4°C in wash buffer. After washing, blots were
incubated with horseradish peroxidase-conjugated donkey anti-rabbit
immunoglobulin (Amersham) for 1 h, and signals were visualized using
enhanced chemiluminescence detection reagents (Amersham).
RESULTS
ICAM-1 expression is stimulated by SPC In order to clarify
the potential inflammatory effect of SPC on epidermal cells, the
expression of a specific inflammation-related receptor, ICAM-1,
on the cell surface of cultured human keratinocytes after SPC
treatment was examined by focal scanning laser microscopy follow-
ing immunostaining with ICAM-1 antibodies. Analysis by focal
scanning laser microscopy revealed that treatment with 10 µM
SPC for 24 h stimulated the expression of ICAM-1 to a greater
extent than did 10 µM SS, and 10 µM SM did not stimulate the
expression of ICAM-1 at all (data not shown). On the other hand,
the expression of vascular cell adhesion molecule-1 was not detected
in control cultured human keratinocytes and even following similar
treatment with 10 µM SPC (data not shown). Fluorescence-
activated cell sorter (FACS) analysis of ICAM-1 expression by
cultured human keratinocytes demonstrated that SPC treatment
significantly enhanced the expression of ICAM-1 after incubation
for 15–24 h in a dose-dependent manner (Figs 1, 2). During these
experiments there was little cytotoxic effect in SPC-treated human
keratinocytes as measured by propidium iodide staining for dead
cells.
Stimulation of ICAM-1 expression by SPC is correlated with
ICAM-1 gene expression To determine whether the enhanced
expression of ICAM-1 on the plasma membrane of cultured human
keratinocytes is associated with increased expression of the ICAM-
1 gene, the effects of SPC on transcriptional levels of ICAM-1
were examined by northern blots. Northern blots using a human
cDNA probe for ICAM-1 revealed that the level of ICAM-1
gene transcription markedly increased when highly proliferating
keratinocytes were exposed for 4–12 h to 20 µM SPC (Fig 3).
SPC induces TNF-a and IL-6 Next, we examined the secretion
levels of several cytokines, including TNF-α, in the medium of
cultured human keratinocytes after 24 h of treatment with 10 µM
SPC. There were increases in the secretion of TNF-α and IL-6,
but only a very slight increase for granulocyte-macrophage colony
stimulating factor among the cytokines tested following treatment
with SPC, and lesser increases were observed following treatment
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with other sphingolipids, SM and SS (Fig 4A–C). TNF-α levels
in the medium of keratinocytes treated at a 10 µM concentration
of SPC significantly increased 2-fold (Fig 4A). SS also elicited a
significant release of TNF-α, albeit much less than elicited by SPC.
The relative potentials of SPC, SS, and SM to induce release of
TNF-α paralleled their effects on ICAM-1 expression, suggesting
a partial autocrine involvement of TNF-α in the increased expres-
sion of ICAM-1.
TNF-a antibodies partially neutralize the SPC-induced
expression of ICAM-1 To clarify the role of TNF-α in the
expression of ICAM-1 induced by SPC, we determined whether
TNF-α antibodies could neutralize SPC-induced ICAM-1 expres-
sion. When various antibodies were added at concentrations of 1
or 10 µg per ml to the keratinocyte cultures prior to treatment
with 20 µM SPC, the expression of ICAM-1 (measured by
Figure 1. FACS analysis of ICAM-1 expression by cultured human
keratinocytes. Keratinocytes were treated for 24 h with various
concentrations (0–20 µM) of SPC. After cells were stripped with pronase
treatment, the cell suspensions were labeled for 30 min at 4°C with anti-
human ICAM-1 monoclonal antibody, followed by fluorescein
isothiocyanate-conjugated anti-mouse IgG and analyzed by
immunofluorescence flow cytometry as described in Materials and Methods.
The cell number is shown on the ordinate and the mean fluoresence
intensity (log scale) is shown on the abscissa.
Figure 2. SPC induces ICAM-1 expression on cultured human
keratinocytes. Time course (A) and concentration dependency (B) of
ICAM-1 induction on keratinocytes following treatment with SPC were
determined by flow-cytometric analysis. Mean fluorescence intensity is
expressed as the mean value 6 SD from three independent experiments.
For the time course study, 20 µM SPC was used. For the concentration
dependency study, an incubation time of 24 h was used.
Figure 3. Northern blots of poly(A)1 RNA isolated from cultured
human keratinocytes. Keratinocytes cultured in SFM without BPE and
EGF were treated with 20 µM SPC for the noted times, following
which total RNA were isolated for northern blot analysis. Extraction of
poly(A) 1 RNA from human keratinocytes was carried out 4 or 12 h
after 20 µM SPC treatment.
Figure 4. Effect of sphingolipid derivatives on the secretion of
cytokines by cultured human keratinocytes. Keratinocytes were
incubated for 24 h with SPC, SS, or SM at indicated concentrations, and
cytokine levels were then assayed in the culture media by enzyme-linked
immunosorbent assay. The values reported are means 6 SD from three
experiments. (A) TNF-α, (B) granulocyte-macrophage colony stimulating
factor, (C) IL-6.
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Figure 5. TNF-a antibodies but not IL-6 or IFN-g antibodies,
partially neutralize SPC-induced expression of ICAM-1 by cultured
human keratinocytes. Keratinocytes were cultured in 6 well plates to
subconfluency. After exchanging the SFM medium to medium without
BPE or EGF, antibodies were added at concentrations of 1 or 10 µg per
ml to the cultures, after which keratinocytes were incubated for 24 h with
20 µM SPC. Cell suspensions were then prepared and were labeled
for 30 min at 4°C with fluorescein-conjugated anti-human ICAM-1
monoclonal antibody and analyzed by immunofluorescence flow cytometry,
as described in Materials and Methods. The cell numbers are shown on the
ordinates and the mean fluoresence intensities (log scale) are shown on the
abscissa. The activities of antibodies used in this experiment are as follows;
anti-TNF-α, 200 pg 5 1 U TNF-α; anti-IL-6, 20 pg 5 1 U IL-6; anti-
IFN-γ, 10 pg 5 1 U IFN-γ. (A) Anti-TNF-α, (B) anti-IL-6, (C) anti-
IFN-γ.
FACS analysis) was partially abolished by TNF-α antibodies at a
concentration of 10 µg per ml, but not by antibodies to IL-6 or
IFN-γ (Fig 5), further supporting the involvement of TNF-α in
the induction of ICAM-1 expression by SPC.
SPC stimulates MAP kinase SPC acts as a potent differentiation
stimulator in keratinocytes, eliciting anti-proliferative effects1 and
stimulation of ICAM-1 expression as shown in this study. Because
MAP kinase has been implicated in the stimulation of cell prolifera-
tion and differentiation (Cowley et al, 1994; Pang et al, 1995), it
was of interest to determine whether the activation of MAP kinase
might be involved in signaling pathways that could account for the
biologic effects of SPC on keratinocytes. Assay of MAP kinase
activity after treatment of human keratinocytes with 10 µM SPC
revealed that SPC induced the rapid activation of MAP kinase
activity within 5 min, which thereafter declined to the baseline
level after 30 min (Fig 6A). In contrast, SM or SS had no significant
effects on activating MAP kinase activity at the same concentration.
In a parallel study, western blot analysis using phospho-MAP kinase
antibodies revealed that 10 µM SPC elicited a marked increase in
phosphorylation of MAP kinase within 5 min, which thereafter
declined to the baseline level after 60 min (Fig 6B).
1Yada Y, Higuchi K, Takagi Y, Imokawa G, Murata Y, Higaki Y,
Kawashima M: The role of sphingosylphophorylcholine generated due to
the abnormal expression of sphingomyelin acylase in atopic dermatitis.
J Dermatol Sci 8:210, 1994 (abstr.)
Figure 6. SPC stimulates MAP kinase. (A) Effects of sphingolipid
derivatives on MAP kinase of cultured human keratinocytes. Keratinocytes
were treated with 10 µM sphingolipid derivatives for the time indicated.
MAP kinase activities in cell lysates were then measured using the p42/
p44 MAP kinase enzyme assay system as described in Materials and Methods.
The values reported are the mean 6 SD of three independent assays. (B)
Western blot analysis using phospho-MAP kinase antibodies in cultured
human keratinocytes after treatment with 10 µM SPC. Keratinocytes were
incubated with 10 µM SPC or 100 ng EGF per ml in 60 mm diameter
culture dishes. Lysates were separated by 10% SDS-polyacrylamide gel
electrophoresis and transferred to immobilon-P PVDF membranes.
Membranes were probed with p44/42 MAP kinase antibody or phospho-
specific p44/42 MAP kinase antibody overnight at 4°C and were then
visualized using enhanced chemiluminescence detection reagents, as
described in Materials and Methods.
DISCUSSION
Increased activities of SM deacylase, which may result in unusually
high levels of SPC, have been found in the epidermis of patients
with AD (Murata et al, 1996). The potential role of SM deacylase
in the pathophysiology of AD was suggested by its deleterious
effects on the function of the stratum corneum as a permeability
barrier, due to the interruption of ceramide biosynthesis (Murata
et al, 1996). Because there are increased levels of SPC (10–40 ng
per mg stratum corneum in AD patients relative to 5–7 pg per mg
in healthy control) in the stratum corneum of patients with AD1
and, based on the biosynthetic mechanism and the generation site
in the skin, because it would be easily predicted that there may be
accumulation or transit release of SPC in the epidermis of AD at
much higher concentrations than those at which stratum corneum
of AD contains it, SPC might play different roles in several
cutaneous symptoms during the elicitation of AD. Increased levels
of SPC have been found in patients with Niemann-Pick disease, a
form of sphingolipidosis that results from a deficiency of sphingomy-
elinase activity, although there are no data on SM deacylase
expression in this disease (Strasberg and Callahan, 1987). The
pathophysiologic role of SPC in Niemann-Pick disease has been
suggested by its deleterious effects on mitochondrial function and
calcium uptake (Strasberg and Callahan, 1988). It is well established
that SPC stimulates cellular proliferation of quiescent Swiss 3T3
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fibroblasts to a greater extent than other known growth factors or
structurally related molecules, including SS and SS-1-phosphate
(Desai et al, 1993). The mitogenic effect of SPC is accompanied
by a rapid rise in intracellular free calcium in viable 3T3 fibroblasts
and a release of AA, but not with an increase in phosphatidic acid
level or changes in cAMP levels. Therefore, the ability of SPC to
act as an extremely potent mitogen for fibroblasts has been suggested
to result from the activation of signaling pathways distinct from
those used by SS or SS-1-phosphate (Desai et al, 1993).
In this study we found that SPC at concentrations ranging from
10 to 20 µM is capable of enhancing the expression of ICAM-1
on the cell surface of human keratinocytes, accompanied by a
marked increase in the expression of ICAM-1 mRNA, which
peaks at 4–12 h. On the other hand, SS is slightly, but SM are not
effective in altering the expression of ICAM-1 on keratinocytes at
a concentration of 10 µM. Based upon the detection of SPC at
the above described levels in the stratum corneum of AD patients,1
and presumably at much higher concentration in the epidermis, it
would be possible that SPC molecules released in the upper
epidermis come in contact with living keratinocytes in vivo at 10–
20 µM levels used in these in vitro experiments. Because the
expression of ICAM-1 on the human keratinocyte cell surface is
known to be stimulated by cytokines such as TNF-α and IL-1α
(Dustin et al, 1988), we examined the secretion levels of several
cytokines, including TNF-α, in the medium of cultured human
keratinocytes after 24 h of treatment with 10 µM SPC. There was
an increased secretion of TNF-α and IL-6 among the cytokines
tested, induced by SPC, whereas SM and SS also stimulated
secretion but to a lesser extent, suggesting the partial autocrine
involvement of TNF-α in the increased expression of ICAM-1.
Consistent with this speculation, the expression of ICAM-1 induced
by SPC was partially abolished by concomitant addition of TNF-
α antibodies but not by IL-6 or IFN-γ antibodies. Because IL-6 is
not directly involved in the expression of ICAM-1 by human
keratinocytes, the biologic role of the increased levels of IL-6
secretion that are elicited by SPC treatment of keratinocytes remains
to be elucidated.
Expression of ICAM-1 is a prerequisite for cells to physically
interact with leukocytes (Springer, 1990; Krutmann, 1994). In
human keratinocytes, binding of ICAM-1 to leukocyte function-
associated antigen-1 molecules on the T cells surface provides a
costimulatory activity necessary for keratinocyte accessory cell
function in superantigen-induced T cell activation (Nickoloff et al,
1993). In addition, keratinocyte ICAM-1 expression plays a pivotal
role in the generation and maintenance of an intraepidermal
infiltrate by forming the molecular matrix to which leukocyte
function-associated antigen-1-expressing leukocytes bind in
inflammatory skin diseases (Kupper, 1989). The observed potential
of SPC to induce ICAM-1 expression by epidermal cells, together
with the ability to secrete the primary inflammatory cytokine TNF-
α, suggests important roles of SPC metabolism in inflammatory
processes of the skin. It should be noted that in some cases ICAM-
1 can be visualized on epidermal keratinocytes in SM deacylase-
evoked skin diseases such as AD (Griffith et al, 1989), where
binding of infiltrating leukocytes, such as T cells, monocytes, and
eosinophils, to epidermal keratinocytes often occurs as one of the
critical immunologic and inflammatory events within the epidermis.
Our studies clearly demonstrate that SPC is an inducer of ICAM-
1 expression for human keratinocytes; however, the signaling
mechanisms involved in this biologic activity are poorly character-
ized at this time. Because A23187 is well known to increase
intracellular free calcium and strongly augments ICAM-1 expression
on keratinocytes (Griffith et al, 1990), the best characterized early
cellular response induced by SPC in human keratinocytes is the
direct induction of Ca21 mobilization from external stores,1 thereby
acting as a potential second messenger. In Swiss 3T3 cells, where
SPC acts as a potent mitogen, it has been reported that addition
of SPC induces a rapid and transient activation of P42 MAP kinase
(Seufferlein and Rozengurt, 1995a,b). MAP kinase, known as an
extracellular signal-related kinase, plays a role as an important
intermediate in the signal transduction pathways leading to the
regulation of gene expression by transcription factor phosphoryla-
tion (Davis, 1993). A recent study speculates that some cellular
stimuli, including TNF-α and IL-1, might work through MAP
kinase activation on nuclear factor kB to activate transcription
(Schreck et al, 1991). In this study, SPC induced a rapid activation
of P42/48 MAP kinase in cultured human keratinocytes within
5 min of incubation, which declined to the baseline level after
30 min. Because the addition of 10–20 µM SPC increased the
expression of ICAM-1 mRNA in keratinocytes within 4 h of
incubation, the most plausible mechanism would involve rapid
events in which intracellular calicum mobilization modulates sig-
naling transduction pathways to activate MAP kinase that in turn
works on nuclear factors such as nuclear factor kB, resulting in the
activation of ICAM-1 associated transcription. Concomitant with
this pathway, it is likely that TNF-α released by SPC treatment
may work synergistically to augument the ICAM-1 expression.
In summary, our results demonstrate that SPC stimulates the
expression of ICAM-1 in human keratinocytes in vitro. This biologic
effect is accompanied by the release of several inflammatory
cytokines, including TNF-α, and the activation of MAP kinase.
More recently, we observed that the skin from patients with AD
exhibits a high activity of SM deacylase that catalyzes liberation of
SPC from SM,2 and that cultured normal human keratinocytes also
contain a significant level of SM deacylase activity even under
nonstimulated conditions.1 Because SPC itself is present at detect-
able levels in cultured normal human keratinocytes and in the
normal stratum corneum,1 SPC provides an attractive agonist to
explore the molecular mechanisms underlying the regulation of
inflammation in human epidermis.
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